Type 2 Diabetes Mellitus and Invokana: An FDA Approved Drug

ISSN: 1875-6417 (Online)
ISSN: 1573-3998 (Print)

Volume 13, 6 Issues, 2017

Download PDF Flyer

Current Diabetes Reviews

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Norman E. Cameron
University of Aberdeen
Aberdeen, Scotland

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Type 2 Diabetes Mellitus and Invokana: An FDA Approved Drug

Current Diabetes Reviews, 9(6): 478-490.

Author(s): Nida Akhtar.

Affiliation: H. No. 1559, near Old P.O. Pakbara, Moradabad-244001, Uttar Pradesh, India.


Diabetes Mellitus is a chronic metabolic disease affecting wide range of people across the globe. In India the rate of subjects being suffered from diabetes is continuously increasing. So, the development of drugs for its effective treatment is essential. Thereby, various attempts have been made to discover newer drugs, to reduce the rate of anti diabetic occurrence. Anti-diabetic drugs were found to treat diabetes mellitus by lowering glucose levels in the blood. Both the use antidiabetic drugs as well as the changes in lifestyle and proper diet can significantly affect the severity of diabetes mellitus and also reduces the symptoms and occurrence of the disease. Researches in the past few years on diabetes mellitus showed that this disease is spreading at a very faster rate, thereby; various attempts have been made to treat it efficaciously. Development and approval of antidiabetic drugs is quite necessary. There are different classes of anti-diabetic drugs reported to treat diabetes. The objective of the present review is to explore Invokana as a newly approved antidiabetic drug for the effective treatment of type 2 diabetes. This review focuses mainly on the various aspects of diabetes mellitus and its treatment perspectives. From the various clinical studies done on Invokana, it was concluded that and Invokana was found to be very effective for the efficacious therapy of diabetes mellitus.


Diabetes, glucose, hypoglycaemic, insulin, metabolism, obesity.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 9
Issue Number: 6
First Page: 478
Last Page: 490
Page Count: 13
DOI: 10.2174/15733998113096660085
Price: $58
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals

Related eBooks

Webmaster Contact: urooj@benthamscience.org Copyright © 2017 Bentham Science